tetano
Editor, Senior Moderator
Viruses
. 2022 Jul 18;14(7):1560.
doi: 10.3390/v14071560.
Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
Kuan-Ting Liu[SUP] 1 2 [/SUP], Yi-Ju Han[SUP] 1 2 [/SUP], Guan-Hong Wu[SUP] 1 2 [/SUP], Kuan-Ying A Huang[SUP] 1 3 [/SUP], Peng-Nien Huang[SUP] 1 3 4 [/SUP]
Affiliations
Abstract
We aimed to review the existing literature on the different types of neutralization assays and international standards for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We comprehensively summarized the serological assays for detecting neutralizing antibodies against SARS-CoV-2 and demonstrated the importance of an international standard for calibrating the measurement of neutralizing antibodies. Following the coronavirus disease outbreak in December 2019, there was an urgent demand to detect neutralizing antibodies in patients or vaccinated people to monitor disease outcomes and determine vaccine efficacy. Therefore, many approaches were developed to detect neutralizing antibodies against SARS-CoV-2, such as microneutralization assay, SARS-CoV-2 pseudotype virus assay, enzyme-linked immunosorbent assay (ELISA), and rapid lateral flow assay. Given the many types of serological assays for quantifying the neutralizing antibody titer, the comparison of different assay results is a challenge. In 2020, the World Health Organization proposed the first international standard as a common unit to define neutralizing antibody titer and antibody responses against SARS-CoV-2. These standards are useful for comparing the results of different assays and laboratories.
Keywords: international standard for SARS-CoV-2; neutralizing antibody detection; serological assays.
. 2022 Jul 18;14(7):1560.
doi: 10.3390/v14071560.
Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
Kuan-Ting Liu[SUP] 1 2 [/SUP], Yi-Ju Han[SUP] 1 2 [/SUP], Guan-Hong Wu[SUP] 1 2 [/SUP], Kuan-Ying A Huang[SUP] 1 3 [/SUP], Peng-Nien Huang[SUP] 1 3 4 [/SUP]
Affiliations
- PMID: 35891540
- DOI: 10.3390/v14071560
Abstract
We aimed to review the existing literature on the different types of neutralization assays and international standards for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We comprehensively summarized the serological assays for detecting neutralizing antibodies against SARS-CoV-2 and demonstrated the importance of an international standard for calibrating the measurement of neutralizing antibodies. Following the coronavirus disease outbreak in December 2019, there was an urgent demand to detect neutralizing antibodies in patients or vaccinated people to monitor disease outcomes and determine vaccine efficacy. Therefore, many approaches were developed to detect neutralizing antibodies against SARS-CoV-2, such as microneutralization assay, SARS-CoV-2 pseudotype virus assay, enzyme-linked immunosorbent assay (ELISA), and rapid lateral flow assay. Given the many types of serological assays for quantifying the neutralizing antibody titer, the comparison of different assay results is a challenge. In 2020, the World Health Organization proposed the first international standard as a common unit to define neutralizing antibody titer and antibody responses against SARS-CoV-2. These standards are useful for comparing the results of different assays and laboratories.
Keywords: international standard for SARS-CoV-2; neutralizing antibody detection; serological assays.